Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
World Journal of Gastroenterology|April 12, 2012
Assessment of disease progression in patients with transfusion-associated chronic hepatitis C using transient elastographyRyota Masuzaki, Ryosuke Tateishi, Haruhiko Yoshida, et al.
Cancer Chemotherapy and Pharmacology|April 15, 2010
A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinomaFumihiko Kanai, Haruhiko Yoshida, Ryosuke Tateishi, et al.
Journal of Gastroenterology and Hepatology|February 14, 2007
Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinomaYuji Kondo, Haruhiko Yoshida, Ryosuke Tateishi, et al.
Hepato-Gastroenterology|December 13, 2006
Age-related comparison of the profiles of patients with hepatocellular carcinomaTomonori Fujishima, Takashi Ishikawa, Yasushi Shiratori, et al.
European Journal of Gastroenterology & Hepatology|July 23, 2014
Cause-specific mortality associated with aging in patients with hepatocellular carcinoma undergoing percutaneous radiofrequency ablationNaoto Fujiwara, Ryosuke Tateishi, Mayuko Kondo, et al.
Hepatology International|September 9, 2023
Development of a transformer model for predicting the prognosis of patients with hepatocellular carcinoma after radiofrequency ablationMasaya Sato, Makoto Moriyama, Tsuyoshi Fukumoto, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 17, 2010
Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient's prognosisYuji Kondo, Shuichiro Shiina, Ryosuke Tateishi, et al.
Proteomics|October 29, 2005
Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatmentTakayuki Kawakami, Yujin Hoshida, Fumihiko Kanai, et al.
European Journal of Immunology|June 23, 2005
Reduced p38 mitogen-activated protein kinase in donor grafts accelerates acute intestinal graft-versus-host disease in miceMiki Ohta, Keisuke Tateishi, Fumihiko Kanai, et al.
Investigational New Drugs|May 16, 2014
Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinomaMasafumi Ikeda, Shuichiro Shiina, Kohei Nakachi, et al.
Pageof 17